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Abstract 29 
A factorial, two-way, experimental design was used for this 10-week nutritional trial, aiming 30 
to elucidate the interactive effects of decreasing dietary protein/lipid level and substitution of fish 31 
oil (FO) with rapeseed oil (RO) on tissue fatty acid (FA) composition and metabolism of large 32 
Atlantic salmon (Salmo salar L.) reared at summer water temperatures (11.6 oC).  The six 33 
experimental diets were isoenergetic and formulated to include either fish oil (FO) or rapeseed oil 34 
(RO - 60% of the added oil) at three dietary protein/lipid levels, specifically 350 g/kg / 350 g/kg, 35 
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330 g/kg / 360 g/kg and 290 g/kg / 380 g/kg of protein/lipid. Final weight, SGR and TGC were 36 
positively affected by the dietary RO inclusion at the expense of FO, while no significant effects 37 
were seen on growth due to the decreasing protein level. The oil source had a significant effect on 38 
muscle and liver FA composition. However, the changes in muscle and liver FA indicate selective 39 
utilization or retention of individual FA and moderate reductions in tissue EPA and DHA. Pyloric 40 
caeca phospholipid FA composition was significantly affected by the two factors and, in some 41 
cases, significant interactions were also revealed. Liver and red muscle β-oxidation capacities were 42 
significantly increased due to RO inclusion, while an interactive effect of the protein level and the 43 
oil source was shown for the white muscle β-oxidation capacity. The results could explain, at least 44 
partially, the better performance that was shown for the RO groups and the enhanced protein 45 
sparing effect.  46 
 47 
 48 
Introduction 49 
In recent years, one of the main research topics in aquaculture nutrition has been the 50 
replacement of fish meals (FM) and fish oils (FO) in the diets for fish exploiting alternative sources 51 
for protein and lipid, respectively. The use of FM and FO in fish nutrition, especially in the 52 
intensive culture of carnivorous species such as Atlantic salmon has been common practice for 53 
years and, to a great extent, still is today. This is because they constitute excellent sources of 54 
essential amino acids and fatty acids (FA), and especially of highly unsaturated fatty acids 55 
(HUFA)(1-3). However, the need for reduction in the consumption of these commodities in aqua 56 
feeds is required for a number of reasons, including environmental and economic concerns, 57 
including sustainability issues, price increases etc(4-8). In addition, there are issues regarding the 58 
quality of the final product, as there is a potential risk of contamination of FM and FO with organic 59 
pollutants(9-13). 60 
Numerous commodities have been successfully tested as alternatives to FM and FO. In the 61 
case of FO replacement, vegetable oils (VO), including rapeseed oil (RO), have been included, 62 
either as single replacements or as part of VO blends. The effects of such dietary alterations have 63 
been recently reviewed(13-15) and can be summarized as causing no detrimental effects on growth 64 
and feed utilization(16-22) or notably, in some cases enhancing growth(21,23,24). However, the dietary 65 
inclusion of RO at expense of FO leads to significant changes in tissue FA compositions, which 66 
reflect the FA compositions of the diets, and FA metabolism, including β-oxidation. It should be 67 
noted that RO’s content of 18:2n-6 and 18:3n-3 is moderate and at a ratio of 2:1 and thus, should 68 
result only in modest deposition of these FA in fish tissues and, perhaps, enhance the endogenous 69 
conversion of 18:3n-3 to 20:5n-3 and 22:6n-3. Also, RO contains high levels of monounsaturated 70 
 3
FA, especially 18:1n-9, which are preferred substrates for energy production by Atlantic salmon 71 
and hence, growth rates of the fish should not be compromised(16,25-27). Alterations of fish tissue FA 72 
profile are of importance given the role of HUFA and especially EPA and DHA,  to human health 73 
and the increasing demand of consumers for nutritious and health promoting products(13). Fish are 74 
unique sources of these FA and hence, their nutritional characteristics should not be compromised.  75 
However, there are issues regarding FM and FO replacement in fish diets which remain 76 
unclear. For instance, the authors of the afore mentioned reviews have pointed out that the 77 
simultaneous reduction of both FM and FO could be challenging due to the expected reduction in 78 
essential FA and amino acids. 79 
In those terms, the investigation of the replacement of FO with a vegetable oil like RO, with 80 
a concurrent reduction of FM is of considerable interest. The use of energy dense diets can be a 81 
potentially useful approach towards the reduction of FM, as such diet formulations, require less 82 
protein by exploiting lipids for energy production and hence, can be potentially advantageous for 83 
the nutrition of carnivorous species, like Atlantic salmon(28,29) Research findings agree that these 84 
diets are performing well in terms of the fish growth and feed utilization, while a sparing effect on 85 
protein by increased dietary oil has also been shown(23,24,30-34). However, in most of these studies 86 
relatively high dietary protein/lipid levels were used and, hence, how much protein reduction can 87 
occur, without performance loss, still needs to be elucidated. Moreover, the dietary protein/lipid 88 
content and the FO replacement with RO, affect tissue FA composition and FA metabolism, 89 
including catabolism via β-oxidation which influences fish growth, while other interactions may 90 
also occur(14,23,24,35).  91 
In an earlier trial we investigated the interactive effects of the dietary protein/lipid ratio and 92 
the inclusion of RO at the expense of FO in the diets of salmon in cold (winter) water 93 
temperatures(24). The results of that study showed a positive effect on fish growth, as well as a 94 
protein sparing effect but also changes in tissues FA composition. Given that, water temperature is a 95 
key-factor in fish nutrition and FA retention and metabolism(36), the impact of even lower dietary 96 
protein/lipid ratios and different lipid sources, in Atlantic salmon reared at high (summer) water 97 
temperatures is of considerable interest. Moreover, the positive effects of RO inclusion on growth 98 
have been associated with changes in the digestibility of FA. The uptake and digestibility of lipids 99 
and ultimately the utilization of diets could be affected by the intestine phospholipid FA 100 
composition and the consequent alterations occurring due to dietary FA changes, especially when 101 
high lipid diets are used.  102 
Hence, the aim of this study was to elucidate the interactive effects of FO replacement with 103 
RO at various dietary protein/lipid ratios on tissue FA compositions and metabolism, including FA 104 
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β-oxidation and phospholipid FA compositions of pyloric caeca, of large Atlantic salmon at high 105 
water temperatures. 106 
 107 
Materials and methods 108 
 Fish and facilities 109 
The 10 week feeding trial was carried out at the Fjord Research Station AS (Helgeland, 110 
Dønna, Norway, 66oN) using Atlantic salmon (Salmo salar) of initial mean weight of 2053g. 111 
Eighteen sea cages of 125 m3 (5x5x5m) were used with approximately 93 fish randomly distributed 112 
in each cage. Prior to the experiment the fish were acclimatised to the trial cages for 63 days at 113 
12oC, being fed a commercial diet from BioMar AS (9 mm; 360 g/kg protein and 350 g/kg fat). 114 
During the experimental period the average water temperature was 11.6 ± 1.1 °C and the salinity 115 
32.5 ± 0.4 g L-1, while the fish were subjected to natural photoperiod. Mortalities were recorded and 116 
dead fish were removed daily. Experimental procedures complied with the Norwegian code of 117 
practice for the care and use of animals for scientific purposes. There are no aspects of this trial that 118 
would cause aggravated or unnecessary harm or stress to the fish involved. 119 
  120 
Experimental diets and feeding 121 
Following a factorial (two-way 3x2) experimental design, six diets were formulated at three 122 
different dietary protein/fat levels and two different levels of FO substitution. Regarding the 123 
protein/lipid level the diets contained 350 g/kg / 350 g/kg (high protein - HP), 330 g/kg / 360 g/kg 124 
(medium protein - MP) and 290 g/kg / 380 g/kg (low protein - LP). For the oil source, FO or RO 125 
were used within each dietary protein/fat level, where crude RO comprised 60% of the total added 126 
oil in the RO diets, the remainder being FO. All diets were isoenergetic (gross energy, GE 25 kJ g-127 
1). The diets were formulated to meet all known nutritional requirements of salmonid fish(3) and 128 
were produced as practical-type extruded pellets (9 mm) at the BioMar TechCentre (Brande, DK). 129 
The ingredients, proximate and fatty acid compositions of the experimental diets are shown in 130 
Tables 1 and 2, respectively. Feeding was carried out by hand to satiation on a daily basis, including 131 
two daily meals with a minimum of 4 hours between them. A lift-up system was used to collect 132 
uneaten feed, which was recorded for accurate calculations of feed intake and FCR. 133 
 134 
Sampling procedure 135 
At the start of the trial the fish were bulk weighed. At the end (10th week) the fish were 136 
individually weighed after being anaesthetized in MS-222 (metacain, 8mg/L). At the end of the trial 137 
another three fish per cage were sampled at random for lipid and fatty acid composition of muscle, 138 
liver and pyloric caeca phospholipids and for β-oxidation determination. Fish were killed with a 139 
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sharp blow to the head and samples of liver and pyloric caeca were dissected and immediately 140 
frozen in liquid nitrogen. Muscle samples, representative of the edible portion, were obtained by 141 
cutting a steak between the dorsal and ventral fins (NQC), which were then skinned, de-boned and 142 
homogenized. For β-oxidation determination samples of liver, red and white muscle were taken 143 
separately and immediately frozen in liquid nitrogen. Samples from the six experimental diets were 144 
also taken to determine proximate and FA compositions. All samples were kept at -20 °C until 145 
further analysis.  146 
 147 
Lipid extraction and fatty acid analyses 148 
Total lipids of tissues and diet samples were extracted by homogenization in 20 volumes of 149 
chloroform/methanol (2 : 1, v/v) containing butylated hydroxytoluene (0.01% w/w, BHT) as 150 
antioxidant(37). Fatty acid methyl esters (FAME) were prepared from total lipid by acid-catalysed 151 
transesterification using 2 mL of 1%H2SO4 in methanol plus 1 mL toluene, as described by 152 
Christie(38), and FAME extraction and purification as described by Tocher & Harvie(39). FAME 153 
were separated and quantified by gas–liquid chromatography (Carlo Erba Vega 8160, Milan, Italy) 154 
using a 30 m x 0.32 mm capillary column (CP wax 52CB; Chrompak Ltd., London, UK). The 155 
carrier gas was hydrogen and the temperature programming used was from 50 to 150 oC at 40 oC 156 
min-1 and then to 225 oC at 2 oC min-1. Individual methyl esters were identified by comparison with 157 
known standards and by reference to published data(40). 158 
In the case of phospholipid FA composition of pyloric cecae, a phospholipid (PL) fraction 159 
was prepared from 0.5 mg of total lipid applied to a 20 x 20 cm silica gel 60 TLC plate (VWR, 160 
Lutterworth, England) and developed in iso-hexane/diethyl ether/acetic acid (80:20:1 v/v/v) and 161 
dried for a few minutes at room temperature. The plate was sprayed lightly with 2, 7, 162 
dichlorofluoricein (0.1% w/v) in 97% methanol (v/v) and the PL bands on the origin scraped from 163 
the plate and placed in a 15 ml test tube. FAME were prepared by acid-catalysed transesterification 164 
in 2 ml of 1% H2SO4 in methanol at 50oC overnight(38). The samples were neutralised with 2.5 ml of 165 
2% KHCO3 and extracted with 5 ml isohexane/diethyl ether (1:1 v/v) + BHT. The samples were 166 
then re-extracted with 5 ml isohexane/diethyl ether (1:1) and the combined extracts dried and 167 
dissolved in 0.3 ml of isohexane prior to fatty acid analysis. 168 
 169 
Peroxisomal β-oxidation capacity 170 
Liver and red and white muscle were weighed and homogenized in 20% (w/v) ice-cold 171 
buffered sucrose solution containing 0.25M sucrose, 0.04M potassium phosphate buffer (pH 7.4), 172 
0.15M KCl, 40mM KF and 1mM N-acetyl cysteine. The resulting total homogenates were then 173 
centrifuged at 1880  g for 10 min at 2°C. The resulting post-nuclear fractions were collected, and 174 
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portions were used immediately to determine β-oxidation capacity. The latter was determined as 175 
acid-soluble products using radiolabelled [1-14C]-palmitoyl-CoA as a substrate as described by 176 
Frøyland et al (41).  177 
Briefly, 250 μL of assay medium were added to 2ml eppendorf tubes. Then 10 μL of [1-178 
14C]palmitoyl-CoA substrate (0.1 μCi/100 μM) were added to each tube. The samples were pre-179 
incubated at room temperature for 2 min. The reaction was started by the addition of homogenate 180 
(30-50 μl for liver and red muscle and 300-500 μl for white muscle, homogenized in 20% (w/v) ice-181 
cold buffered sucrose solution as described above) and the reaction continued for 10 min. The 182 
reaction was stopped by addition of 150 μL of 1.5 M KOH. Then 25 μL FAF-BSA (100mg/ml) 183 
were added, the tubes were vortexed and 500 μL of ice-cold 4M HClO4 (perchloric acid) were 184 
added. The tubes were centrifuged at 1880 x g for 10 min. Aliquots of 500 μL were placed in 185 
scintillation vials, 2.5 ml of scintillant added and the radioactivity determined in a scintillation 186 
counter. The protein content of the samples was determined according to the Lowry method(42).  187 
 188 
Calculations and statistical analysis 189 
The following formulae were applied to the data:  190 
Feed Conversion Ratio (FCR) = feed intake (g) x wet weight gain-1 (g) 191 
Specific Growth Rate (SGR, %/day) = 100 x [lnW1 - lnW0] x (days) -1  192 
Thermal Growth Coefficient (TGC, x 1000)  = 1000 x [(W1)1/3 - (W0)1/3] x (days x Temp. oC)-1 193 
Protein productive value (PPV, g protein gain x g protein ingested−1) = [(P1W1−P0W0) x (PF x 194 
cumulative feed intake) −1] 195 
where W0 and W1 are the initial and final fish mean weights in grams, P0 and P1 are the initial and 196 
final protein concentrations of the fish, PF is the protein concentration of the feed on a dry matter 197 
basis, and cumulative feed intake was determined in grams on a dry matter basis. 198 
Factorial (two-way) ANOVA was used to analyse the effects of the protein/fat ratio (protein 199 
level), dietary RO inclusion (oil source) and their interactions on FA composition of tissues and β-200 
oxidation. When the interaction of the two factors was significant, multiple comparison testing was 201 
performed for both factors to investigate the simple main effects, that is the main effect of one 202 
factor at a given level of the other, while the main effects were not taken into account(43). Data 203 
which were identified as non-homogeneous (Levene’s test) were subjected to square root, log or 204 
arcsin transformation before analysis. Differences were regarded as significant when P < 0.05(43). 205 
All the data are presented as means ± SD (n = 3) and all statistical analyses were performed using 206 
SPSS 14.0 (SPSS Inc, 2005). The graphs were created using Prism 4 (Graphpad Software Inc., San 207 
Diego, USA). 208 
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 209 
Results 210 
Diet proximate and fatty acid composition 211 
The analysed protein / lipid content of the diets, was 349 g/kg / 350 g/kg, 333 g/kg / 358 212 
g/kg, 293 g/kg / 384 g/kg for HP, MP and LP, respectively (Table 1). The Digestible Protein / 213 
Digestible Energy (DP/DE) ratio was 14.5, 13.5 and 12.3 for the HP, MP and LP diets, respectively; 214 
DP and DE were calculated using the ADC values for protein and energy found in this trial 215 
(Karalazos et al., 2010 Aquaculture, submitted for publication). The diets contained either 100% FO 216 
or a blend of 40% FO and 60% RO with a consequential effect on the total lipid FA profiles (Table 217 
2). Briefly, the FO diets contained approximately 36% total saturated FA, largely 16:0 (approx. 218 
20%), except for the HP-FO diet which had a slightly higher total saturated FA content (40.4%). 219 
The total monoenes were 26%, predominantly 18:1n-9 and 16:1n-7. The total n-6 PUFA were low 220 
(4.5%), half of which was 18:2n-6. Lastly, the total n-3 PUFA were as high as 32%, mainly as EPA 221 
and DHA (18.5% and 8%, respectively). The 60% inclusion of RO resulted in the reduction of 16:0, 222 
and consequently of the total saturated FA, by half, compared to the FO diets. The total monoenes 223 
almost doubled, largely due to the high amount of 18:1n-9 (38.5%). The total n-6 PUFA in the RO 224 
diets increased 3-fold, up to 14%, mainly as 18:2n-6 (13% of total FA). EPA decreased by 70% and 225 
DHA by more than half (values were 6% and 3%, respectively) and hence the total n-3 PUFA were 226 
reduced by half (17%). The n-3/n-6 PUFA ratio was 7 and 1.2 for the FO and RO diets, 227 
respectively. 228 
 229 
Growth 230 
At the beginning of the trial fish had a mean weight of 2053g. At the end of the trial all 231 
groups showed good performance, mean weight ranging from 3340.2g to 3664.2g, for HP-RO and 232 
MP-RO, respectively (Table 3). The oil source had a significant effect (two-way ANOVA, P < 233 
0.05) on growth; specifically fish fed the RO diets had higher final weight, SGR and TGC 234 
compared to fish fed the FO diets. There was no significant effect due to the protein level and no 235 
significant interactions were shown. FCR was not affected by any of the factors and varied from 236 
0.99 to 1.10. Lastly, PPV was significantly affected by both factors. LP diets had significantly 237 
higher PPV than the other two groups (0.41, 0.43 and 0.47, for HP, MP and LP, respectively), while 238 
the RO groups had higher PPV compared to the FO groups (0.42 vs. 0.46, for FO and RO, 239 
respectively). These results are described in detail in Karalazos et al., 2010 Aquaculture, submitted 240 
for publication. 241 
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Tissue fatty acid compositions 243 
The total lipid content and the fatty acid composition of muscle and liver from fish fed the 244 
six experimental diets for 10 weeks are shown in Table 4 and 5, respectively. The muscle total lipid 245 
varied from 138.0 to 156.5 mg lipid g-1 tissue. The liver lipid content was much lower, compared to 246 
that of muscle, ranging from 50.1 to 64.9 mg lipid g-1 tissue. Neither the dietary protein level nor 247 
the RO inclusion affected the muscle and liver lipid contents and no significant interactions were 248 
shown by two-way ANOVA. 249 
Regarding the FA composition of muscle and liver, they were significantly affected by the 250 
RO but not by the protein level and no significant interactions between the two factors were shown. 251 
Specifically, the inclusion of RO resulted in a significant increase of 18:1n-9, total monoenes, 252 
18:2n-6, 20:2n-6, total n-6 PUFA and 18:3n-3. On the other hand, all saturates, including total 253 
saturated FA, 16:1n-7, 22:1, AA, EPA, DHA, total n-3 FA and the n-3/n-6 ratio were significantly 254 
reduced when the fish were fed the diets containing RO. 255 
Notably in muscle, EPA was reduced by half (10.4 vs. 5.2%, for FO vs. RO, respectively), 256 
while the reduction in DHA was more moderate (7.8 vs. 5.0% for FO vs. RO, respectively). 18:1n-9 257 
increased from 20.9% to 35.1%, 18:2n-6 from 6.6% to 11.6% and 18:3n-3 from 2.0% to 4.6% for 258 
FO and RO groups, respectively. Similarly in liver, EPA was reduced from 16.0% to 9.9% and 259 
DHA from 16.2% to 13.2% for FO and RO groups, respectively. The increase between FO and RO 260 
groups for 18:1n-9, 18:2n-6 and 18:3n-3 was 13.8% vs. 27.9%, 1.9% vs. 7.6% and 0.5% v. 2.9%, 261 
respectively. 262 
The differences (Δ) between diet and muscle fatty acid concentrations for the six 263 
experimental diets are shown in Table 6, where negative Δ values indicate lower values in muscle 264 
compared with diet, whereas positive values indicate accumulation in tissues relative to diet. Thus, 265 
the saturated FA, ARA, EPA, and the total n-3 PUFA were utilized to a higher extent by the fish fed 266 
the FO diets compared to the RO groups. DHA appeared to be slightly utilized in the FO groups but 267 
was accumulated in the muscle in the RO groups. On the contrary, 18:1n-9, 18:2n-6 and 18:3n-3 268 
were found in higher concentrations in the muscle in the FO groups but were utilised in the RO 269 
groups. Likewise, the differences (Δ) between diet and liver fatty acid concentrations for the six 270 
experimental diets are shown in Table 7. In liver the 14:0 and 16:0 were utilized in all groups, 271 
although lower Δ values were found in the FO groups. Similarly to the muscle, 18:1n-9, 18:2n-6 272 
and 18:3n-3 in liver were much more utilized in the RO groups compared to the FO ones. Lastly, 273 
18:0, ARA and DHA were accumulated in liver in all groups. 274 
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 275 
Pyloric caeca phospholipid FA composition 276 
Pyloric caeca phospholipid FA composition (Table 8) was significantly affected mainly by 277 
the dietary oil source, although in some cases a significant main effect due to the protein level, 278 
and/or significant interactions between the two factors were also shown (two-way ANOVA, P < 279 
0.05). Pyloric caeca phospholipid comprised almost half as n-3 PUFA (41.6-49.9%), mainly DHA 280 
and EPA, followed by saturated FA (24.3-30.5%), largely 16:0, and monoenes (15.0-24.0%) while 281 
n-6 PUFA were less than 9% (5.3 -9.0%). DHA was the most abundant FA varying from 18.9% to 282 
25.8% and being affected significantly both by the oil source (FO > RO) and the protein content 283 
(reduced with lower protein content). EPA was also found at high levels (16.1-22.1%) and was 284 
affected significantly by both factors, while significant interactions were also found. As shown in 285 
Figure 1 the RO groups had a significantly lower EPA content at all protein levels, whereas EPA 286 
content was significantly higher for the LP diet compared to HP but only when FO was the oil 287 
source. Regarding total saturated FA there was a significant effect due to the oil source (FO > RO) 288 
and the same pattern was shown for 16:0. Total monoenes, and mainly 18:1n-9 were significantly 289 
increased due to the dietary inclusion of RO. However, significant interactions were found for 290 
18:1n-9 showing an effect of protein content (higher 18:1n-9 level for the LP diet vs. HP and MP) 291 
but only for the RO diets. Total n-6, mainly 18:2n-6, were increased in fish fed the RO diet, while 292 
ARA was decreased. Noticeably, all n-6 FA were at relatively low levels. Significant interactions 293 
were shown for 18:2n-6 resulting in a significantly higher content in fish fed LP diets compared to 294 
HP and MP for the RO diets. 295 
 296 
Peroxisomal β-oxidation capacity 297 
The peroxisomal palmitoyl-CoA oxidation capacity in liver, red and white muscle is shown 298 
in Table 9. The peroxisomal β-oxidation capacity in liver ranged from 6.6 to 12.5 pmol/min/mg 299 
protein, in red muscle from 26.7 to 36.3 pmol/min/mg protein and in white muscle from 1.1 to 1.6 300 
pmol/min/mg protein. In liver and red muscle β-oxidation capacity was significantly affected by the 301 
oil source (P = 0.035 and P = 0.034 for liver and red muscle, respectively). Specifically, RO 302 
inclusion resulted in significantly higher β-oxidation in both liver (7.2 vs. 9.7, for FO and RO, 303 
respectively) and red muscle (28.2 vs. 33.7, for FO and RO, respectively). However, in white 304 
muscle there was a significant interaction of the two factors (protein level and oil source) and 305 
hence, the simple main effects of the two factors were tested, as demonstrated in Figure 2. 306 
Specifically, the HP group had a significantly higher β-oxidation capacity than MP and LP when 307 
FO was the oil source, whereas in contrast, the β-oxidation capacity in HP was lower than the other 308 
two groups when RO was included in the diet. Regarding the effects of the oil source on β-oxidation 309 
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capacity at the three protein levels, the ranking was FO > RO for HP, RO > FO for MP while FO 310 
and RO did not significantly differ at LP. 311 
 312 
Discussion 313 
Growth 314 
The effects and interactions of the two factors on growth are thoroughly discussed in 315 
Karalazos et. al. 2010, Aquaculture, submitted form publication. Briefly, it was shown that, in 316 
agreement with previous studies(23,30-34) no negative effects on growth and FCR were observed 317 
when the fish were fed with low protein / high lipid diets, even at protein levels below 300 g/kg. 318 
This is much lower than what had been previously tested and of significant importance regarding 319 
the tolerance in low protein diets and the utilization of lipid for energy. Moreover, the dietary 320 
inclusion of RO at expense of FO had a positive effect on final weight, SGR and TGC. Such an 321 
effect had been reported by a couple of studies(23,24) and possibly relates to the positive effect of low 322 
n-3 FA diets towards higher growth for large salmon(21,44). This effect is probably explained by the 323 
higher digestibility of the RO, and other VO, FA, and hence better utilization of the dietary oil for 324 
energy by the fish. This theory is confirmed by the digestibility results of the present study 325 
(Karalazos et. al. 2010, Aquaculture, submitted form publication). Moreover, the increased β-326 
oxidation and the changes in the pyloric caeca phospholipids discussed below could also have 327 
played a significant role. 328 
Lastly, a positive effect of increased dietary lipid content on protein retention and, hence, on 329 
protein sparing has been previously reported(23,24,32,33) and was also confirmed in the present study 330 
as the LP diets showed a higher PPV. The inclusion of RO at the expense of FO resulted in a 331 
positive effect on PPV, also. The potential effects of dietary VO in protein sparing in fish are 332 
largely unknown, however the results of the present study are supported by the increased β-333 
oxidation capacity that was shown in tissues of Atlantic salmon fed with RO diets compared to the 334 
FO diets. The results showing increased catabolism of FA for energy production may suggest a 335 
protein sparing effect. The β-oxidation results are discussed further below. 336 
 337 
Tissue fatty acid composition 338 
Tissue total lipid FA composition reflects the FA composition of the diet, usually following 339 
linear correlations between the concentrations of individual FA in the diet and the 340 
tissues(16,17,19,21,24,45,46). The results of the present study are in agreement with the previous studies 341 
showing a reduction in saturated FA, 16:1n-7, 20:4n-6, EPA, DHA and n-3/n-6 ratio, respective to 342 
the reductions in the dietary FA, with inclusion of RO. Similarly, the increase of 18:1n-9, 18:2n-6 343 
and 18:3n-3 in the diets containing RO, compared to the FO diets, was reflected in muscle and liver 344 
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FA. It is clear that, since the FA compositions of the diets were affected by the oil source only, the 345 
changes in the muscle and liver FA compositions were also due to the dietary RO inclusion and, as 346 
expected, the dietary protein level had no significant effect on the tissue FA composition.  347 
The changes in muscle and liver FA indicate selective utilization or retention of individual 348 
FA. It has been shown previously that when specific FA are in abundance in the diets they are 349 
selectively utilized for energy production, via β-oxidation, and perhaps to a lesser extent for 350 
desaturation and elongation. In contrast, when FA, and especially n-3 HUFA, are limited in the diet 351 
they are retained or deposited in the tissues(16,17,19). For example, in the present study 18:1n-9 was 352 
increased almost 4-fold, 18:2n-6 more than 5-fold and 18:3n-3 9-fold in the diets when FO was 353 
replaced with RO, however the respective increases in muscle were less than or around 2-fold for 354 
all of the above FA, while in liver it was approx. 2-fold for 18:1n-9, less than 4-fold for 18:2n-6 and 355 
less than 6-fold for 18:3n-3, indicating selective utilization of these FA in the RO groups. On the 356 
other hand, although the reduction of EPA and DHA was more than 60% in the RO diets the 357 
decrease in muscle was approximately 50% for EPA and 35% for DHA, while in liver the reduction 358 
was approximately 35% for EPA and 20% for DHA indicating a selective retention of these FA in 359 
the tissues when the dietary supply was reduced. These results are also supported by the Δ values 360 
for muscle and liver, that is the differences between diet and tissue fatty acid concentrations. It was 361 
shown that, when provided at high concentrations, 18:1n-9, 18:2n-6 and 18:n-3 were highly utilised 362 
in both muscle and liver and EPA and DHA were accumulated in the tissues when dietary supply 363 
was reduced. In other animals, the selective retention of essential FA in specific tissues is believed 364 
to occur by a mechanism of reacylation of sn-2-monoacylglycerols by hepatic microsomal activity 365 
of monoacylglycerol acyltransferase (MGAT), during lipolysis(47). However, the moderate 366 
reductions of EPA and DHA shown in the present study may also be partially affected by the 367 
enhanced endogenous desaturation and elongation of dietary 18:3n-3(48-50). 368 
Furthermore, it is noteworthy that the results of the present trial suggest that the inclusion of 369 
RO up to 60%, at the expense of FO, in diets of Atlantic salmon at various dietary protein / lipid 370 
levels caused only moderate reductions in tissue EPA and DHA. This was also shown by Karalazos 371 
et al(24) where fish were reared at low water temperatures. Reductions in n-3 HUFA affect the 372 
quality of the final product, compromise its high nutritional value for the human consumer and 373 
should be avoided(13). Hence, such results, leading to moderate reductions of EPA and DHA, are 374 
promising for the use of VO in commercial diets, although the present trial was conducted over a 375 
short time period, which could have masked the full extent of the FA changes that could occur over 376 
the whole production cycle of salmon. 377 
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 378 
Pyloric caeca phospholipid FA composition 379 
Phospholipids are of importance in lipid digestion in fish, playing a significant role in the 380 
structure of cell membranes, of lipoproteins for the transport of lipids in the blood and lymph and 381 
also in forming intra-luminal mixed micelles along with bile salts and dietary lipids(51). 382 
Phospholipids in fish contain mainly 16:0 and 18:1n-9 at the sn-1 position and 20:5n-3 and 22:6n-3 383 
at the sn-2 position(26). Hence, the intestine phospholipid FA composition and the consequent 384 
alterations occurring due to dietary FA changes may affect the uptake and digestibility of lipids and 385 
ultimately the utilization of diets, especially when high lipid diets are used. Pyloric caeca is a major 386 
site in the intestine duct for nutrient uptake and the most significant section for lipid uptake after 387 
their digestion(52). In the present study focus was given to the interactive effects of the protein/lipid 388 
level and oil source in the FA composition of pyloric caeca.  389 
In the present study it was shown that, regardless of the dietary treatment, n-3 PUFA was the 390 
major FA group in pyloric caeca phospholipids, consisting mainly of DHA and EPA, followed by 391 
saturated FA, largely 16:0, and monoenes (15.0-24.0%) while n-6 PUFA were less than 9% (5.3 -392 
9.0%), which is in accordance with previous reports (26). The high abundance of these FA could 393 
have also been enhanced by their high recovery rate into enterocyte phospholipids(53,54).  394 
However, the dietary changes had significant effects on the phospholipids FA, mainly due to 395 
the oil source but also due to protein/lipid level, although to a small extent, while significant 396 
interactions were also observed. Specifically, the dietary inclusion of RO at expense of FO, resulted 397 
in significant reductions of DHA, EPA, 16:0 and 20:4n-6, and significant increases of 18:1n-9 and 398 
18:2n-6. On the other hand, the effect of the protein content was also significant in some cases with 399 
contradicting results, including 18:0 (HP < LP) and DHA (HP > LP). Lastly, significant interactions 400 
of the two factors were also revealed by two-way ANOVA for some FA, including 18:1n-9 and 401 
18:2n-6 with a significant increase due to the protein content (HP > LP) only for the RO groups, 402 
while EPA had a significant decrease due to the protein content (HP < LP) only for the FO groups 403 
(for these FA the effect of the oil source was significant at all protein/lipid levels). These changes 404 
reflected the changes in the dietary FA compositions, similarly to the muscle and liver total lipid FA 405 
compositions, although to a relatively smaller extent. However, altering the relative proportions of 406 
FA in intestine phospholipids, as an effect of the use of vegetable oils in the diets and more 407 
interestingly of the protein/lipid level or the interactive effects of the two factors, is most likely to 408 
affect their structure and consequently their role in the digestion and uptake of lipids and nutrients. 409 
The present study showed that lipid digestibility was improved due to RO inclusion but also (for FO 410 
only) due to low protein/high lipid diets (data presented and discussed in Karalazos et. al. 2010, 411 
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Aquaculture, submitted for publication). However, the clarification of the exact mechanisms 412 
involved requires further investigation.  413 
 414 
Peroxisomal β-oxidation capacity 415 
The peroxisomal β-oxidation activity was measured in liver, red and white muscle. 416 
Conducting the assay on-site was not possible and hence the samples of tissues had to be frozen on 417 
dry ice and transferred to the Institute of Aquaculture in Scotland where analysis took place. 418 
Therefore, the measurement of the total β-oxidation activity was not possible and the results 419 
obtained represent the peroxisomal β-oxidation capacity. Previous studies in Atlantic salmon have 420 
shown that different tissues/organs have very different β-oxidation capacities as a result of their 421 
unique and different energy requirements, depending on their functions(55-60). In agreement with 422 
that, between the three tissues assessed in the present study, red muscle had the highest β-oxidation 423 
activity and white muscle the lowest. However, it should be noted that the β-oxidation capacities of 424 
these tissues, and the consequent ranking, were expressed on a tissue protein content basis. 425 
Considering that white muscle accounts for more than 60% of the total body mass of Atlantic 426 
salmon, it becomes clear the its role in energy production for the fish is the most significant(55,56). 427 
It is well documented that tissue β-oxidation capacities are affected by various factors, 428 
including the diet and especially the dietary FA composition(50,56,57,60,61). Specific FA, such as 16:0, 429 
18:1n-9, 22:1n-11 and 20:1n-9 are readily catabolized, although 18:3n-3, 18:2n-6 and even EPA 430 
and DHA are also good substrates for β-oxidation, especially when provided at high levels(56,59,62). 431 
Hence, dietary changes, incorporating VO, could affect the β-oxidation capacities of tissues. 432 
However, the results of previous studies are contradictory. Tocher et al.(50) showed that β-oxidation 433 
capacity was not affected either by the oil content or the oil type in diets of Atlantic salmon. On the 434 
contrary, Stubhaug et al.(56) reported that dietary RO inclusion had a positive effect on β-oxidation. 435 
The results of the present study showed a significant increase in liver and red muscle β-oxidation 436 
capacities due to RO inclusion. This could explain, at least partially, the better performance that was 437 
shown for the RO groups and the enhanced protein sparing effect. However, in white muscle an 438 
interactive effect of the protein level and the oil source was shown, suggesting a higher β-oxidation 439 
capacity for the FO groups than the RO ones at the HP level, whereas RO groups had higher values 440 
for the other two protein levels, although the difference was significant only for the MP diet. The 441 
higher β-oxidation capacity of the HP-FO group could be due to the higher content of saturated FA 442 
in that diet, although if the hypothesis is correct it remains unclear why such an effect was not 443 
reflected in the other two tissues.  444 
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 445 
Conclusions 446 
In conclusion, the investigation of the interactive effects of dietary protein/ lipid level and 447 
FO replacement showed that, low protein / high lipid diets can be used safely in large Atlantic 448 
salmon nutrition with regard to the growth and FCR, while the inclusion of RO at the expense of 449 
FO can enhance the growth of the fish by, increased protein sparing and β-oxidation. In terms of the 450 
the tissue FA compositions, they were significantly affected by the RO inclusion reflecting the FA 451 
composition of the diets. However, the reduction in EPA and DHA, resulting from the dietary FA 452 
changes, was only moderate and hence, the impact on the final product quality, in terms of the 453 
nutritional value for the human consumer, was limited. Further studies on the longer term use of 454 
diets are therefore warranted. 455 
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Figure 1. Means of 18:1n-9 (a) and 20:5n-3 (b) (g/100g total fatty acids) of total phospholipids of 628 
pyloric caeca from Atlantic salmon fed the six experimental diets, in a two-way ANOVA, showing 629 
the effects of the two factors and their interaction.  630 
For each oil source, values denoted with different letters are significantly different; uppercase or 631 
lowercase letters correspond to FO or RO, respectively. Within each protein level the significant 632 
differences between FO and RO values are marked with an asterisk. 633 
 634 
Figure 2. Means of the peroxisomal β-oxidation capacity (pmol/min/mg protein) of white muscle 635 
from Atlantic salmon fed the six experimental diets, in a two-way ANOVA, showing the effects of 636 
the two factors and their interaction.  637 
For each oil source, values denoted with different letters are significantly different; uppercase or 638 
lowercase letters correspond to FO or RO, respectively. Within each protein level the significant 639 
differences between FO and RO values are marked with an asterisk. 640 
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Table 1. Diet formulations, proximate compositions (g/kg) and energy content (kJ/g) of the six 644 
experimental diets fed to Atlantic salmon for 10 weeks. 645 
HP-FO MP-FO LP-FO HP-RO MP-RO LP-RO 
Component (g/kg) 
Fishmeal* 402 340 268 402 340 268 
Oil seed and legume 
seed meals 181 190 190 181 190 190 
Binder 135 130 190 135 130 190 
Fish oil 304 330 351 122 132 141 
Rapeseed oil† 0 0 0 182 198 211 
Premixes‡ 9 10 11 9 10 11 
Composition (g/kg) 
Moisture 49 69 69 51 73 67 
Dry Matter 951 931 931 949 927 933 
Protein 353 338 291 345 328 296 
Lipid 350 349 386 351 368 382 
Ash 81 75 63 79 73 63 
Gross Energy (kJ/g) 25.25 25.22 25.32 25.47 25.41 25.36 
DP/DE§ 15.4 14.0 12.3 13.7 13.0 12.3 
 646 
*South-American, Anchoveta oil 647 
†European, non-GM, double-low quality rapeseed oil  648 
‡Vitamin and mineral premixes prepared according to BioMar A/S commercial standards. Includes 649 
crystaline amino acids and Carophyl pink to provide 40mg/kg astaxanthin (DSM Roche, Basel, 650 
Switzerland) 651 
§Digestible Protein/Digestible Energy 652 
 653 
654 
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Table 2. Fatty acid compositions (g/100g total fatty acids) of the six experimental diets fed to 655 
Atlantic salmon for 10 weeks. 656 
Fatty Acid HP-FO MP-FO LP-FO HP-RO MP-RO LP-R0 
14:0 8.8 8.5 8.3 3.4 3.0 2.8 
16:0 23.2 20.3 20.2 12.1 10.9 10.2 
18:0 5.9 4.9 5.0 3.8 4.3 3.5 
20:0 0.6 0.5 0.5 0.7 0.8 0.7 
22:0 1.3 1.2 1.2 1.9 2.5 1.7 
Total saturates* 40.4 35.9 35.7 22.0 21.7 19.1 
16:1n-7 8.0 8.8 8.7 3.3 3.1 3.0 
18:1n-9 9.5 10.9 11.3 37.7 37.7 40.0 
18:1n-7 3.2 3.3 3.4 3.7 3.0 3.1 
20:1n-9 1.5 1.4 1.3 1.6 1.5 1.5 
22:1 1.7 1.7 1.5 1.3 1.1 0.9 
24:1n-9 0.5 0.5 0.6 0.4 0.4 0.3 
Total monoenes† 24.7 26.8 27.0 47.9 47.1 49.1 
18:2n-6 2.1 2.4 2.7 12.5 13.0 13.8 
20:2n-6 0.1 0.2 0.2 0.1 0.1 0.1 
20:4n-6 1.1 1.1 1.1 0.4 0.5 0.4 
22:5n-6 0.3 0.3 0.3 0.1 0.1 0.1 
Total n-6‡ 4.1 4.6 4.8 13.2 14.0 14.8 
18:3n-3 0.6 0.7 0.8 6.2 6.3 6.7 
18:4n-3 2.1 2.3 2.2 0.8 0.8 0.7 
20:4n-3 0.6 0.7 0.6 0.2 0.2 0.2 
20:5n-3 17.6 19.0 18.8 5.8 6.0 5.8 
22:5n-3 1.9 2.0 2.0 0.7 0.7 0.6 
22:6n-3 8.0 8.0 7.9 3.2 3.2 3.0 
Total n-3§ 30.8 32.7 32.5 16.9 17.3 17.1 
Total PUFA 34.9 37.3 37.3 30.1 31.3 31.9 
(n-3) / (n-6) 7.5 7.1 6.8 1.3 1.2 1.2 
 657 
* Includes 15:0 658 
† Includes 16:1n-9 & 20:1n-7 659 
‡ Includes 18:3n-6, 20:3n-6 & 22:4n-6 660 
§ Includes 20:3n-3 & 22:4n-3 661 
 662 
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Table 3. Growth and performance of Atlantic salmon fed the six experimental diets for 10 weeks (Mean values (n 3) and standard deviations) 663 
HP-FO  MP-FO LP-FO HP-RO MP-RO LP-RO TWO-WAY ANOVA P 
Mean SD  Mean SD Mean SD Mean SD Mean SD Mean SD protein oil prot x oil
Start Weight, g 2031.7 8.3  2097.0 9.6 2031.7 32.6 2065.3 28.5 2055.7 47.2 2038.3 18.6  
End Weight, g 3340.2 136.0  3491.1 134.2 3352.9 156.2 3591.8 158.7 3664.2 148.0 3405.7 92.1 0.085 0.032 0.483
FCR* 1.07 0.06  1.10 0.09 1.06 0.05 0.99 0.05 1.02 0.05 1.09 0.11 0.587 0.262 0.376
SGR† 0.86 0.07  0.88 0.07 0.86 0.08 0.95 0.05 0.99 0.03 0.88 0.06 0.262 0.025 0.422
TGC‡ 3.41 0.29  3.54 0.32 3.44 0.34 3.85 0.25 4.04 0.17 3.53 0.26 0.202 0.021 0.414
PPV§ 0.40 0.03  0.41 0.01 0.44 0.02 0.43 0.01 0.44 0.02 0.51 0.06 0.003 0.003 0.294
 664 
* Feed Conversion Ratio 665 
† Specific Growth Rate 666 
‡ Thermal Growth Coefficient 667 
§ Protein Productive Value 668 
669 
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Table 4. Total lipid (mg lipid/g tissue) and fatty acid compositions (g/100g total fatty acids) of muscle from Atlantic salmon fed the experimental diets 670 
for 10 weeks (Mean values (n 3) and standard deviations) 671 
 672 
HP-FO  MP-FO LP-FO HP-RO MP-RO LP-RO  TWO-WAY ANOVA P 
Mean SD   Mean  SD  Mean  SD  Mean  SD  Mean   SD  Mean  SD  protein oil prot x oil
Total Lipid (mg 
lipid/g tissue) 142.1 14.2 142.2 24.5 138.0 9.7 147.5 13.3 156.5 14.1 143.8 3.8 0.621 0.242 0.843 
Fatty acid 
14:0 5.8 1.3 5.6 0.4 5.7 0.3 3.4 0.1 3.2 0.1 3.4 0.3 0.766 0.000 0.988 
16:0 17.4 2.9 16.3 1.3 17.0 1.5 12.4 0.4 11.9 0.2 12.3 0.7 0.677 0.000 0.941 
18:0 4.0 0.7 3.7 0.4 3.8 0.4 3.1 0.1 3.1 0.0 3.1 0.2 0.695 0.001 0.903 
Total saturated* 28.6 4.8 26.9 2.7 28.3 3.0 20.5 1.6 19.7 1.1 20.5 2.1 0.705 0.000 0.957 
16:1n-7 6.9 0.4 7.3 0.2 7.1 0.3 4.3 0.1 4.0 0.1 4.2 0.1 0.977 0.000 0.106 
18:1n-9 21.3 0.6 21.3 0.9 20.2 1.1 33.7 1.5 36.3 1.4 35.3 0.7 0.131 0.000 0.090 
18:1n-7 3.6 0.1 3.8 0.3 3.8 0.3 3.4 0.4 3.0 0.2 3.4 0.1 0.427 0.004 0.214 
20:1n-9 2.7 0.1 2.8 0.0 2.5 0.2 2.9 0.2 3.0 0.1 2.8 0.1 0.033 0.004 0.632 
22:1 2.5 0.2 2.5 0.2 2.2 0.2 2.1 0.2 2.0 0.2 2.0 0.2 0.147 0.001 0.489 
24:1n-9 0.5 0.1 0.6 0.1 0.5 0.1 0.4 0.1 0.4 0.0 0.5 0.2 0.571 0.425 0.216 
Total monoenes† 37.7 0.4 38.6 0.6 36.7 1.7 47.1 1.9 49.0 1.5 48.4 1.0 0.190 0.000 0.336 
18:2n-6 6.8 0.6 6.5 0.4 6.6 0.0 11.3 0.1 11.7 0.2 11.8 0.4 0.862 0.000 0.177 
20:2n-6 0.4 0.1 0.4 0.0 0.4 0.0 0.6 0.0 0.7 0.0 0.6 0.1 0.194 0.000 0.484 
20:3n-6 0.2 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.224 0.000 0.308 
20:4n-6 0.7 0.1 0.8 0.1 0.7 0.1 0.4 0.0 0.4 0.0 0.4 0.0 0.875 0.000 0.476 
Total n-6‡ 8.5 0.8 8.4 0.3 8.3 0.1 12.8 0.2 13.2 0.2 13.3 0.5 0.797 0.000 0.379 
18:3n-3 2.1 0.3 2.0 0.2 2.0 0.0 4.6 0.1 4.7 0.1 4.6 0.3 0.924 0.000 0.637 
18:4n-3 1.3 0.1 1.4 0.1 1.4 0.1 0.8 0.0 0.8 0.0 0.8 0.1 0.855 0.000 0.475 
20:4n-3 1.0 0.1 1.0 0.1 1.0 0.1 0.7 0.0 0.7 0.0 0.7 0.0 0.746 0.000 0.419 
20:5n-3 9.9 1.6 10.6 1.2 10.7 0.9 5.7 0.3 5.0 0.1 5.0 0.6 0.996 0.000 0.338 
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22:5n-3 3.1 0.5 3.3 0.2 3.5 0.2 2.1 0.2 1.8 0.1 1.8 0.2 0.924 0.000 0.184 
22:6n-3 7.6 1.5 7.7 1.0 8.0 0.6 5.4 0.5 4.8 0.4 4.7 0.8 0.924 0.000 0.574 
Total n-3 PUFA§ 25.2 3.8 26.1 2.7 26.7 1.9 19.6 1.2 18.1 0.6 17.8 1.9 0.981 0.000 0.451 
Total PUFA 33.7 4.4 34.5 2.9 35.0 2.0 32.4 1.4 31.3 0.7 31.1 2.4 0.996 0.039 0.680 
(n-3) / (n-6) 2.9 0.3   3.1  0.2  3.2  0.2  1.5  0.1  1.4   0.0  1.3  0.1   0.761 0.000 0.049 
 673 
* Includes 15:0, 20:0, 22:0 674 
† Includes 16:1n-9 & 20:1n-7 675 
‡ Includes 18:3n-6, 22:4n-6 & 22:5n-6 676 
§ Includes 20:3n-3 & 22:4n-3  677 
 678 
679 
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Table 5. Total lipid (mg lipid g-1 tissue) and fatty acid compositions (g/100g total fatty acids) of liver from Atlantic salmon fed the experimental diets 680 
for 10 weeks (Mean values (n 3) and standard deviations) 681 
 682 
  HP-FO  MP-FO LP-FO HP-RO MP-RO LP-RO  TWO-WAY ANOVA P 
  Mean SD   Mean  SD  Mean  SD  Mean  SD  Mean   SD  Mean  SD protein oil prot x oil
Total Lipid (mg 
lipid/g tissue) 61.4 5.1 64.9 7.1 53.8 8.1 60.7 3.3 54.9 11.0 50.1 5.8 0.094 0.182 0.535 
Fatty acid 
14:0 2.7 0.8 2.8 0.7 2.7 0.7 1.5 0.3 1.3 0.3 1.4 0.3 0.997 0.000 0.907 
16:0 14.2 1.1 14.3 1.8 15.6 1.0 10.5 0.5 11.5 1.3 12.0 1.1 0.144 0.000 0.759 
18:0 7.9 0.3 7.6 1.0 7.7 0.9 5.2 0.2 5.6 0.6 5.3 0.5 0.955 0.000 0.705 
Total saturated* 25.5 1.7 25.9 2.6 26.9 2.2 18.2 0.8 19.6 2.0 20.2 1.6 0.355 0.000 0.899 
16:1n-7 4.6 0.6 4.9 0.6 4.4 0.7 2.4 0.0 1.9 0.2 2.0 0.2 0.467 0.000 0.269 
18:1n-9 14.8 1.0 14.5 1.4 12.0 1.4 29.8 2.6 26.9 4.5 27.1 4.0 0.038 0.000 0.106 
18:1n-7 4.3 0.1 4.4 0.3 3.9 0.2 3.3 0.3 2.7 0.4 3.0 0.2 0.148 0.000 0.103 
20:1n-9 2.2 0.1 2.1 0.2 1.6 0.2 3.8 0.2 3.6 0.3 3.1 0.3 0.001 0.000 0.776 
22:1 0.9 0.1 0.8 0.1 0.8 0.1 0.7 0.1 0.5 0.1 0.5 0.1 0.033 0.000 0.442 
24:1n-9 0.6 0.1 0.7 0.2 0.6 0.1 0.5 0.0 0.5 0.1 0.6 0.1 0.834 0.164 0.739 
Total monoenes† 27.7 1.3 27.7 2.4 23.5 2.4 40.7 2.8 36.3 5.1 36.3 4.5 0.125 0.000 0.467 
18:2n-6 1.9 0.2 1.9 0.2 1.9 0.3 7.6 0.3 7.2 0.7 8.2 0.7 0.298 0.000 0.355 
20:2n-6 0.4 0.0 0.4 0.0 0.4 0.1 1.7 0.0 1.9 0.1 1.7 0.2 0.203 0.000 0.299 
20:3n-6 0.3 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.954 0.082 0.598 
20:4n-6 2.7 0.2 2.4 0.3 3.0 0.3 1.7 0.3 2.0 0.5 2.1 0.5 0.196 0.001 0.329 
Total n-6‡ 5.9 0.3 5.7 0.1 6.3 0.1 11.8 0.0 11.8 0.1 12.6 0.3 0.000 0.000 0.162 
18:3n-3 0.5 0.0 0.6 0.1 0.5 0.1 2.9 0.1 2.7 0.4 3.1 0.3 0.391 0.000 0.352 
18:4n-3 0.4 0.0 0.4 0.1 0.4 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.614 0.000 0.651 
20:4n-3 1.3 0.1 1.5 0.2 1.3 0.2 0.8 0.0 0.7 0.0 0.8 0.0 0.897 0.000 0.132 
20:5n-3 15.3 1.1 15.6 0.2 17.2 0.9 9.1 0.9 10.5 1.3 10.1 1.1 0.068 0.000 0.236 
22:5n-3 6.9 0.4 7.7 1.1 6.6 0.6 3.3 0.1 3.2 0.2 3.0 0.1 0.033 0.000 0.364 
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22:6n-3 16.3 1.1 15.0 1.2 17.2 1.5 12.3 1.3 14.2 2.2 13.0 2.4 0.738 0.003 0.199 
Total n-3 PUFA§ 40.9 1.6 40.8 0.3 43.3 0.2 29.3 2.1 32.3 3.2 30.9 3.2 0.120 0.000 0.114 
Total PUFA 46.8 1.8 46.5 0.2 49.6 0.2 41.1 2.0 44.1 3.1 43.5 3.2 0.141 0.000 0.293 
(n-3) / (n-6) 7.0   0.4   7.2  0.1  6.9  0.1  2.5  0.2  2.7   0.3  2.5  0.3  0.155 0.000 0.967 
 683 
* Includes 15:0, 20:0, 22:0 684 
† Includes 16:1n-9 & 20:1n-7 685 
‡ Includes 18:3n-6, 22:4n-6 & 22:5n-6 686 
§ Includes 20:3n-3 & 22:4n-3  687 
 688 
689 
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Table 6. Differences (Δ)* between diet and muscle fatty acid concentrations (g/100g total fatty acids) for the six experimental treatments 690 
Fatty Acid HP-FO MP-FO LP-FO HP-RO MP-RO LP-RO 
14:0 -3.0 -2.9 -2.6 0.0 0.1 0.6 
16:0 -5.8 -3.9 -3.2 0.3 1.0 2.1 
18:0 -1.9 -1.3 -1.2 -0.6 -1.2 -0.4 
Total saturates† -11.8 -9.0 -7.4 -1.4 -1.9 1.4 
16:1n-7 -1.1 -1.5 -1.6 1.0 0.9 1.2 
18:1n-9 11.7 10.4 8.9 -4.0 -1.4 -4.7 
Total monoenes‡ 13.0 11.7 9.7 -0.8 1.9 -0.7 
18:2n-6 4.7 4.1 3.9 -1.2 -1.2 -2.0 
20:4n-6 -0.4 -0.4 -0.4 0.0 -0.1 0.0 
Total n-6§ 4.4 3.8 3.5 -0.4 -0.8 -1.5 
18:3n-3 1.5 1.3 1.2 -1.6 -1.6 -2.1 
20:5n-3 -7.7 -8.4 -8.1 -0.1 -1.0 -0.8 
22:6n-3 -0.4 -0.2 0.1 2.2 1.6 1.8 
Total n-3 -5.6 -6.6 -5.8 2.7 0.8 0.7 
 691 
* Negative Δ values indicate lower values in muscle compared with diet, whereas positive values indicate accumulation in muscle relative to diet. 692 
† Includes 15:0, 20:0, 22:0 693 
‡ Includes 16:1n-9, 18:1n-7, 20:1n-9, 20:1n-7, 22:1 & 24:1n-9 694 
§ Includes 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 & 22:5n-6 695 
 Includes 18:4n-3, 20:3n-3, 20:4n-3, 22:4n-3 & 22:5n-3 696 
697 
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Table 7. Differences (Δ)* between diet and liver fatty acid concentrations (g/100g total fatty acids) for the six experimental treatments 698 
 699 
Fatty Acid HP-FO MP-FO LP-FO HP-RO MP-RO LP-RO 
14:0 -6.2 -5.7 -5.6 -1.9 -1.7 -1.4 
16:0 -9.0 -6.0 -4.6 -1.6 0.6 1.7 
18:0 2.0 2.7 2.8 1.5 1.3 1.7 
Total saturates† -14.9 -10.0 -8.8 -3.7 -2.0 1.1 
16:1n-7 -4.1 -3.9 -4.3 -1.1 -1.5 -1.3 
18:1n-9 5.3 3.6 0.7 -7.9 -10.8 -13.0 
Total monoenes‡ 3.0 0.8 -3.5 -7.2 -10.8 -12.8 
18:2n-6 -0.3 -0.5 -0.7 -4.9 -5.8 -5.7 
20:4n-6 1.6 1.3 1.9 1.3 1.6 1.7 
Total n-6§ 1.8 1.1 1.5 -1.5 -2.2 -2.2 
18:3n-3 -0.1 -0.2 -0.3 -3.3 -3.5 -3.6 
20:5n-3 -2.2 -3.4 -1.7 3.3 4.5 4.3 
22:6n-3 8.3 7.0 9.3 9.1 10.9 10.1 
Total n-3 10.1 8.1 10.9 12.4 15.0 13.8 
 700 
* Negative Δ values indicate lower values in liver compared with diet, whereas positive values indicate accumulation in liver relative to diet. 701 
† Includes 15:0, 20:0, 22:0 702 
‡ Includes 16:1n-9, 18:1n-7, 20:1n-9, 20:1n-7, 22:1 & 24:1n-9 703 
§ Includes 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 & 22:5n-6 704 
 Includes 18:4n-3, 20:3n-3, 20:4n-3, 22:4n-3 & 22:5n-3 705 
706 
 30 
Table 8. Fatty acid compositions (g/100g total fatty acids) of total phospholipids of pyloric caeca from Atlantic salmon fed the experimental diets for 707 
10 weeks (Mean values (n 3) and standard deviations) 708 
HP-FO  MP-FO LP-FO HP-RO MP-RO LP-RO TWO-WAY ANOVA P 
Fatty acid Mean SD   Mean  SD  Mean  SD  Mean  SD  Mean   SD  Mean  SD protein oil prot x oil
14:0 2.4 0.1 2.3 0.1 2.4 0.2 1.2 0.1 1.2 0.3 1.1 0.1 0.808 0.000 0.698 
16:0 20.5 0.3 21.0 0.3 20.9 0.5 16.7 0.3 17.1 0.8 16.9 0.4 0.340 0.000 0.946 
18:0 6.1 0.2 6.7 0.5 6.4 0.6 5.9 0.4 6.3 0.1 6.7 0.2 0.037 0.480 0.327 
Total saturated* 29.5 0.4 30.5 0.8 30.3 0.8 24.3 0.2 25.2 1.1 25.4 0.9 0.079 0.000 0.847 
16:1n-7 2.9 0.1 2.9 0.3 3.0 0.3 1.3 0.0 1.3 0.2 1.2 0.1 0.902 0.000 0.548 
18:1n-9 6.2 0.4 6.2 0.2 6.2 0.3 14.6 0.6 15.2 0.4 16.5 0.3 0.006 0.000 0.004 
18:1n-7 3.5 0.1 3.5 0.1 3.6 0.1 2.9 0.1 2.9 0.2 3.4 0.2 0.002 0.000 0.006 
20:1n-9 0.8 0.1 0.8 0.1 0.7 0.0 1.4 0.2 1.5 0.1 1.3 0.2 0.134 0.000 0.790 
22:1 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.4 0.3 0.1 0.1 0.231 0.785 0.659 
24:1n-9 1.1 0.1 1.0 0.1 0.9 0.1 1.0 0.1 1.0 0.0 1.0 0.1 0.394 0.682 0.375 
Total monoenes† 15.2 0.5 15.0 0.7 15.0 0.6 21.9 1.0 22.6 1.2 24.0 0.7 0.162 0.000 0.076 
18:2n-6 1.1 0.1 1.1 0.1 1.3 0.2 4.6 0.1 4.6 0.2 5.2 0.2 0.000 0.000 0.008 
20:2n-6 0.2 0.0 0.2 0.0 0.2 0.0 0.9 0.1 0.9 0.2 0.8 0.1 0.481 0.000 0.550 
20:3n-6 0.2 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.3 0.0 0.022 0.000 0.046 
20:4n-6 3.0 0.2 2.8 0.1 3.0 0.2 2.2 0.1 2.1 0.1 2.0 0.1 0.487 0.000 0.321 
22:5n-6 0.6 0.0 0.6 0.0 0.6 0.0 0.5 0.0 0.5 0.0 0.5 0.0 0.109 0.000 0.854 
Total n-6‡ 5.4 0.2 5.3 0.1 5.5 0.0 8.8 0.2 8.5 0.4 9.0 0.2 0.049 0.000 0.612 
18:3n-3 0.3 0.0 0.3 0.0 0.3 0.0 1.9 0.0 1.8 0.1 2.0 0.1 0.008 0.000 0.054 
18:4n-3 0.3 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.911 0.000 0.827 
20:4n-3 0.4 0.0 0.4 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.4 0.0 0.010 0.424 0.417 
20:5n-3 19.3 0.6 20.7 0.2 22.1 0.2 16.1 1.1 16.1 0.3 16.7 1.0 0.004 0.000 0.041 
22:5n-3 3.8 0.2 3.7 0.1 3.5 0.3 3.5 0.1 3.6 0.1 3.2 0.1 0.003 0.024 0.464 
22:6n-3 25.8 0.7 23.8 0.9 22.7 0.6 22.6 0.1 21.3 1.4 18.9 0.2 0.000 0.000 0.384 
Total n-3 PUFA§ 49.9 0.9 49.2 0.9 49.3 0.6 45.0 1.2 43.7 1.9 41.6 1.2 0.034 0.000 0.129 
Total PUFA 55.3 0.8 54.4 0.9 54.8 0.6 53.8 1.1 52.2 2.3 50.6 1.2 0.071 0.001 0.216 
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(n-3) / (n-6) 9.2   0.5   9.4  0.2  9.0  0.1  5.1  0.2  5.1   0.1  4.6  0.1  0.014 0.000 0.666 
 709 
* Includes 15:0, 20:0, 22:0 710 
† Includes 16:1n-9 & 20:1n-7 711 
‡ Includes 18:3n-6 & 22:4n-6 712 
§ Includes 20:3n-3 & 22:4n-3  713 
 714 
715 
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 716 
Table 9. Peroxisomal β-oxidation capacity (pmol/min/mg protein) of liver. red and white muscle from Atlantic salmon fed the experimental diets for 717 
10 weeks (Mean values (n 3) and standard deviations) 718 
 719 
  HP-FO  MP-FO  LP-FO  HP-RO  MP-RO  LP-RO  TWO-WAY ANOVA P 
  Mean SD   Mean  SD  Mean  SD  Mean  SD  Mean   SD  Mean  SD protein oil prot x oil
Liver 7.2 2.6 6.6 0.9 7.7 1.8 7.8 1.1 8.7 3.7 12.5 1.9 0.121 0.035 0.288 
Red Muscle 30.0 2.6 28.0 2.6 26.7 4.6 36.3 8.2 31.2 4.4 33.6 4.5 0.430 0.034 0.796 
White Muscle 1.6 0.1 1.2 0.1 1.3 0.0 1.1 0.1 1.6 0.0 1.4 0.2 0.908 0.719 0.000 
 720 
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 724 
 725 
Figure 1. 726 
727 
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 729 
 730 
Figure 2. 731 
 732 
